Vogenx, Inc.
corporate_fare Company Profile
Vogenx, Inc. (NASDAQ:VOGX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for VOGX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-17, rated 8/10. Across its 2 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above. Recent SEC coverage for VOGX spans 10-Q, 424B4.
Recent high-impact activity:
- Vogenx's First 10-Q Flags Material Weaknesses and Restatement
- Vogenx Prices $81.25M IPO at $13.00/Share, Lists on Nasdaq
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 25,518 shares in VOGX as of the September 15, 2026 settlement, a 40.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 37.7% of VOGX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for VOGX, detected from its recent SEC filings · based on capital-structure filings through 2026-08-19.
IPO Priced at $13.00/Share · Net Proceeds to Fund Clinical Trials
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →